Division has crept into the African Democratic Congress following reports of its adoption by former Vice President Atiku Abubakar and the 2023 presidential candidate of the Labour Party, Peter Obi ...

The African Democratic Congress (ADC) said it has undertook bold step towards repositioning itself as a leading political force ahead of the 2027 general elections, declaring itself the coalition ...

Lukman made the clarification in the wake of reports that the coalition had settled for ADC following the gale of defections by opposition leaders and federal lawmakers to the APC in the past few ...

What makes this candidate ideal is that it is an antibody-drug conjugate [ADC] that targets DLL3-expressing solid tumors. Two Catalysts In 2025 For ADC Candidate Could Launch Another Solid Program ...

The African Democratic Congress (ADC) has criticized the ruling All Progressives Congress (APC) for leading Nigeria into unprecedented economic decline since it took power in 2015. Dr. Mani Ahmed ...

The Voya Infrastructure Industrials and Materials Fund (NYSE:IDE) is a closed-end fund or CEF that investors can purchase in order to obtain exposure to the high-yielding and recession-resistant ...

The governorship candidate of the African Democratic Congress (ADC) in Anambra State, Patrick Obianyo, has resigned from the position, citing the burden of the aspiration as the reason. Obianyo ...

By integrating terminal functionality into the IDE, Junie enhances overall efficiency and reduces the cognitive load associated with managing multiple tools. A defining characteristic of Junie is ...

"MHB088C has demonstrated robust efficacy with great safety profiles, with no major hematological toxicity or ILD, positioning the program as a best-in-class B7-H3 ADC," Cao added. "With Qilu's ...

Massachusetts-based Mersana shared initial phase 1 data on Emi-Le, an antibody-drug conjugate (ADC) that targets B7-H4, in January. The biotech is now running the expansion portion of the study in ...

Designed to tackle the most pressing challenges in modern software development, this next-generation IDE and AI assistant promises to transform how teams collaborate and innovate. From streamlined ...

SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted ...